Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001144204-19-028195

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

George Robert E. · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-05-22 Grant or award : show line 1 in the form Stock option (right to buy) +15,000 85,000 D
Loading xslF345X03/tv522431_4.xml…